rheumatology
Autoinflammatory diseases

First line biologics recommended in new PsA treat-to-target guidance


New guidelines for psoriatic arthritis (PsA) recommend a treat-to-target approach with first-line use of TNFi biologics and smoking cessation. Published by the American College of Rheumatology (ACR) and National Psoriasis Foundation (NPF), the new guidelines also include recommendations for psoriatic spondylitis, predominant enthesitis, and treatment of patients who also have IBD, diabetes, or serious infections. ...

Already a member?

Enter your email to keep reading.


OR